Search Results 131-140 of 17323 for prolia
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...
Medical professionals can find detailed pharmacogenomic testing information and resources from the Mayo Clinic Center for Individualized Medicine.
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
This treatment involves injecting cement into broken spinal bones. Osteoporosis is the most common cause of fractures in the spine.
The purpose of this study is to use photographs of infants, both normal and diagnosed with Craniosynostosis, to train a facial recognition algorithm to ...
This slow-growing blood cancer mainly affects people over 60. Treatments and lifestyle changes may reduce complications and ease symptoms.
The purpose of this study is to learn about cell function in different tissues of the eye in various ocular diseases via transcriptomics in the Mayo Clinic ...
About this study. We are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.